Naturally produced extracellular matrix is an excellent substrate for canine endothelial cell proliferation and resistance to shear stress on PTFE vascular grafts

Thrombosis and Haemostasis

Volumn 78, Issue 5, 1997, Pages 1392-1398

  Schneider, A ^a   Chandra, M ^a   Lazarovici, G ^a   Vlodavsky, I ^b   Merin, G ^a   Uretzky, G ^a   Borman, J B ^a   Schwalb, H ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; POLITEF;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CELL ADHESION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; CULTURE MEDIUM; DOG; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN; SHEAR STRESS; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

EID: 0030727598     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1665417     Document Type: Article

References (49)

1. Schneider A, Melmed RN, Schwalb H, Karck M, Vlodavsky I, Uretzky G. An improved method for endothelial cell seeding on PTFE small caliber vascular grafts. J Vase Sug 1992; 15: 649-56.
2. Schneider A, Schwalb H, Vlodavsky I, Uretzky G. An improved method of endothelial seeding on small caliber prosthetic vascular grafts coated with natural extracellular matrix. Clinical Materials 1993; 13: 51-5.
3. Schneider PA, Kotze HF, Du P Heyns A, Hanson SR. Thromboembolic potential of synthetic vascular grafts in baboons. J Vasc Surg 1989; 10: 75-82.
4. Szilagyi DE. Vascular substitutes 1981. Achievements, disappointment, prospects. J Cardiovasc Surg (Torino) 1982; 23: 183-93.
5. Stanley JC, Burkel WE, Ford JW, Vinter DW, Kahn RH, Whitehouse Jr WM, Graham LM. Enhanced patency of small-diameter, externally supported Dacron iliofemoral grafts seeded with endothelial cells. Surgery 1982; 92: 994-1005.
6. Allen BT, Long JA, Clark RE, Sicard GA, Hopkins KT, Welch MJ. Influence of endothelial cell seeding on platelet deposition and patency in small diameter Dacron arterial grafts. J Vase Surg 1984; 1: 224-33.
7. Beiden T, Schmidt S, Falkow L, Sharp W. Endothelial cell seeding of small diameter vascular grafts. Trans Am Soc Artif Intern Organs 1982; 28: 173-7.
8. Schmidt SP, Hunter TJ, Sharp WV, Malindzak GS, Evancho MM. Endothelia! cell-seeded four-millimeter Dacron vascular grafts: Effects of blood flow manipulation through the grafts. J Vasc Surg 1984; 1: 434-41.
9. Rosenman JE, Kempczinski RF, Pearce WH, Silberstein EB. Kinetics of endothelial cell seeding. J Vasc Surg 1985; 2: 778-84.
10. Zilla P, Fasol R, Deutsch M, Fischlein T, Minar E, Hammerle A, Krupicka O, Kadletz M. Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: preliminary report. J Vasc Surg 1987; 6: 535-41.
11. Walker MG, Thomson GJL, Shaw JW. Endothelial cell seeded versus non-seeded ePTFE grafts in patients with severe peripheral vascular disease. In: Endothelialization of Vascular Grafts. Zilla P, Fasol R, Deutsch M (eds). Karger 1987; 245-8.
12. Fasol R, Zilla P, Deutsch M, Grimm M, Fischlein T, Lautle G. Human endothelial cell seeding: evaluation of its effectiveness by platelet parameters after one year. J Vasc Surg 1989; 9: 432-6.
13. Herring MB, Gardner A, Glover J. Seeding human arterial prostheses with mechanically derived endothelium: the detrimental effect of smoking. J Vasc Surg 1984; 1: 279-89.
14. Herring MB, Compton RS, Gardner AL, LeGrand DR. Clinical experience with endothelial seeding in Indianapolis. In: Endothelialization of Vascular Grafts. Zilla P, Fasol R, Deutsch M (eds). Karger 1987; 218-24.
15. Herring MB, Baughman MS, Glover J. Endothelium develops on seeded human arterial prostheses: a brief clinical note. J Vasc Surg 1985; 2: 727-30.
16. Ortenwal P, Wadenvik II, Kutti J, Risberg B. Reduction in deposition of Indium-111 labeled platelets after autologous endothelial seeding of Dacron aortic bifurcation grafts in humans: a preliminary report. J Vasc Surg 1987; 6: 17-25.
17. Ortenwal P, Wadenvik II, Risberg B. Reduced platelet deposition on seeded versus unseeded segments of expanded polytetrafluoroethylene grafts: clinical observations after a 6 month follow-up. J Vasc Surg 1989; 10: 374-80.
18. Kesler KA, Herring MB, Arnold MP, Glover JI, Park HM, Helmus MN, Bendick PJ. Enhanced strength of endothelial attachment on polyester elastomer and PTFE graft surfaces with fibronectin substrate. J Vasc Surg 1986; 3: 58-64.
19. Dalsing MC, Kevorkian M, Raper B, Nixon C et al. An experimental collagen-impregnated Dacron graft: potential for endothelial seeding. Ann Vasc Surg 1989; 3: 127-33.
20. Vohra RK, Thomson GJL, Shamara H, Carr HMH, Walker M. Effect of shear stress on endothelial cell monolayers on expanded polytetrafluoroethylene (ePTFE) grafts using preclot and fibronectin matrices. Eur J Vasc Surg 1990; 4: 33-41.
21. Prendiville EJ, Coleman JE, Callow AD, Gould KE, Laliberte-Verdon S, Ramberg K, Conolly RJ. Increased in-vitro incubation time of endothelial cells on fibronectin-treated ePTFE increases cell retention in blood flow. Eur J Vasc Surg 1991; 5: 311-9.
22. Gospodarowicz D, Moran J, Braun D, Birdwell C. Clonal growth of bovine vascular endothelial cells, fibroblast growth factor as a survival agent. Proc Nat Acad Sci USA 1976; 73: 4120-4.
23. Gospodarowicz D, Mescher AI, Birdwell CR. Stimulation of corneal endothelial cell proliferation in vitro by fibroblast and epidermal growth factors. Exp Eye Res 1977; 25: 75-87.
24. Dewey CF. Fluid mechanics of arterial flow. In: Advances in experimental medicine and biology. Wolf S, Werthessen N (eds.). New York: Plenum Press 1979; 55-103.
25. Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton JW, Wilner G, Vlodavsky I. Thrombin immobilized to extracellular matrix is a mitogen for vascular smooth muscle cells: Non-enzymatic mode of action. Cell Reg 1990; 1: 453-63.
26. Vlodavsky I, Greenburg G, Johnson LK, Gospodarowicz D. Vascular endothelial cells maintained in the absence of fibroblast growth factor undergo structural and functional alterations that are incompatible with their in vivo differentiated properties. J Cell Biol 1979; 83: 468-86.
27. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaelli R, Sasse J, Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987; 84: 2292-6.
28. Vlodavsky I, Bar-Shavit R, Korner G, Fuks Z. Extracellular matrix-bound growth factors, enzymes and plasma proteins. In: Basement membranes: Cellular and molecular aspects. Rohrbach DH, Timpl R (eds). Orlando: Academic Press Inc. 1993; 327-43.
29. Franke RP, Grafe M, Schnittler H, Seiffge D, Drenckhahn D. Induction of human vascular endothelial stress fibers by fluid shear stress. Nature 1984; 307: 648-9.
30. Reutelingsperger CPM, Van Gool RGJ, Heijnen V, Frederik P, Lindhout T. The rotating disc as a device to study the adhesive properties of endothelial cells under differential shear stresses. J Mat Sci: Mat in Med 1994; 5: 361-7.
31. Lavee J, Martinowitz U, Mohr R, Goor D, Golan M, Langsam J, Malik Z, Savion N. The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations. J Thor Cardiovasc Surg 1989; 97: 204-12.
32. Golan M, Modan M, Lavee J, Martinowitz U, Savion N, Goor D, Mohr R. Transfusion of fresh whole blood stored (4° C) for short period fails to improve platelet aggregation on extracellular matrix and clinical hemostasis after cardiopulmonary bypass. J Thor Cardiovasc Surg 1990; 99: 354-60.
33. Vlodavsky I, Eldor A, Hyam E, Atzmon R, Fuks Z. Platelet interaction with the extracellular matrix produced by cultured endothelial cells: A model to study the thrombogenicity of isolated subendothelial basal lamina. Thromb Res 1982; 28: 179-91.
34. Bellon JM, Bujan J, Honduvilla NG, Hernando A, Navlet J. Endothelial cell seeding of polytetrafluoroethylene vascular prostheses coated with a fibroblastic matrix. Ann Vasc Surg 1993; 7: 549-55.
35. Lalka SG, Oelker LM, Malone JM, Duhamel RC et al. A cellular vascular matrix: a natural endothelial cell substrate. Ann Vasc Surg 1989; 3: 108-17.
36. Ingber DE. Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc Natl Acad Sci USA 1990; 87: 3579-83.
37. Zilla P, Fasol R, Dudeck U, Siedler S, Preiss P, Fischlein T, Muller-Glauser W, Battelia-Eberle G, Sanan D, Odell J, Reichart B. In situ cannulation, microgrid follow-up and low density plating provide first passage endothelial cell mass cultures for in vitro lining. J Vasc Surg 1990; 12: 180-9.
38. Fischlein T, Zilla P, Eberl T, Puschmann R, Meinhart J, Minar E, Deutsch M. Initial clinical data on human in vitro endothelialization of vascular prostheses. In: Applied Cardiovascular Biology 1990-1991. Zilla P, Fasol R, Callow A (eds.). Karger 1991.
39. Zilla P, Deutsch M, Meinhart J, Puschmann R, Eberl T, Minar E, Dudczak R, Lugmaier H, Schmidt P, Noszian I, Fischleim T. Clinical in vitro endothelialization of femoropopliteal grafts: An actuarial follow-up over three years. J Vasc Surg 1994; 19: 540-8.
40. Schoen FJ. Interventional and surgical pathology: clinical correlations and basic principles. Philadelphia: Saunders 1989; 241: 79.
41. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimai hyperplasia - a review. J Vasc Surg 1991; 13: 885-91.
42. Anderson JM, Hering TH, Abbuhl MF. Human vascular grafts: cellular and extracellular matrix components. In: Arterial surgery: new diagnostic and operative techniques. Bergen JJ, Yao JST (eds.). New York: Grune & Stratton 1988; 21-9.
43. Ziats NP, Anderson JM. Atherosclerosis and healing aberrations in clinical and experimental vascular grafts. In: Atherosclerosis and arteriosclerosis: human pathology and experimental animal methods and models. White RA (ed.). Boca Raton: CRC Press 1989; 289-302.
44. Hering TH, Suzuki Y, Anderson JM. Collagen type distribution distributing in healing of synthetic arterial prostheses. Conn Tiss Res 1986; 15: 141-54.
45. Anderson JM, Hering TH, Suzuki Y. Studies on the healing of human vascular grafts: quantitative analysis of collagen and collagen types. In: Vascular grafts: safety and performance, ASTM STP 898. Hambic HE, Kantrowitz A, Sung P (eds.). Philadelphia: American Society for Testing and Materials 1986: 180-8.
46. Trelsted RL, Carvalho ACA. Type IV and type A-B collagens do not elicit platelet aggregation or the serotonin release reaction. J Lab Clin Med 1979; 93: 499-505.
47. Parson TJ, Haycraft DL, Hoak JC, Sage H. Diminished platelet adherence to type V collagen. Arteriosclerosis 1983; 3: 589-98.
48. Koenig JM, Chahine A, Ratnoff OD. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV and V. J Lab Clin Med 1991; 117: 523-7.
49. Ziats NP, Anderson JM. Human vascular endothelial cell attachment and growth inhibition by type V collagen. J Vasc Surg 1993; 17: 710-8.